KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
Open accessAbstract
Melanoma is the most lethal form of skin cancer and treatment of metastatic melanoma remains challenging. BRAF/MEK inhibitors show only temporary benefit due the occurrence of resistance and immunotherapy is effective only in a subset of patients. To improve patient survival, there is a need to better understand molecular mechanisms that drive melanoma growth and operate downstream of the mitogen activated protein kinase (MAPK) signaling. The Krüppel-like factor 4 (KLF4) is a zinc-finger transcription factor that plays a critical role in embryonic development, stemness and cancer, where it can act either as oncogene or tumor suppressor. KLF4 is highly expressed in post-mitotic epidermal cells, but its role in melanoma remains unknown. Here, we address the function of KLF4 in melanoma and its interaction with the MAPK signaling pathway. We find that KLF4 is highly expressed in a subset of human melanomas. Ectopic expression of KLF4 enhances melanoma cell growth by decreasing apoptosis. Conversely, knock-down of KLF4 reduces melanoma cell proliferation and induces cell death. In addition, depletion of KLF4 reduces melanoma xenograft growth in vivo. We find that the RAS/RAF/MEK/ERK signaling positively modulates KLF4 expression through the transcription factor E2F1, which directly binds to KLF4 promoter. Overall, our data demonstrate the pro-tumorigenic role of KLF4 in melanoma and uncover a novel ERK1/2-E2F1-KLF4 axis. These findings identify KLF4 as a possible new molecular target for designing novel therapeutic treatments to control melanoma growth.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Upregulation of pioneer developmental organizers such as SOX2, KLF4, β-catenin, SNAIL-1, c-MYC, TBX3, and BCL6 is reported downstream of BRAF/MAPK-driven tumor.
“Even upregulation of pioneer developmental organizers, such as SOX2, KLF4, β-catenin, SNAIL-1, c-MYC, TBX3, BCL6, et al., are reported downstream of BRAF/MAPK-driven tumor, the pathways causing lineage reprogramming are not clear12,15,30–36.”
From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · see citing works
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,592 · see citing works
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · see citing works
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048 · see citing works
Klf4 is a transcription factor required for establishing the barrier function of the skin
Segre, J. A., Bauer, C., & Fuchs, E. V. (1999) · Nature Genetics · doi:10.1038/11926 · Cited by 793 · see citing works
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0070 · Cited by 676 · see citing works
Shields, J. M., Christy, R. J., & Yang, V. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20009 · Cited by 652 · see citing works
Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 583 · see citing works
Stecca, B. A., Mas, C., Clement, V., Zbinden, M., Correa‐Rocha, R., Piguet, V., Beermann, F., & Altaba, A. R. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700776104 · Cited by 525 · see citing works
Self-citationMelanoma: from mutations to medicine
Tsao, H., Chin, L., Garraway, L. A., & Fisher, D. E. (2012) · Genes & Development · doi:10.1101/gad.191999.112 · Cited by 496 · see citing works
Yu, F., Li, J., Chen, H., Fu, J., Ray, S. K., Huang, S., Zheng, H., & Ai, W. (2011) · Oncogene · doi:10.1038/onc.2010.591 · Cited by 469 · see citing works
The melanoma revolution: From UV carcinogenesis to a new era in therapeutics
Lo, J. A., & Fisher, D. E. (2014) · Science · doi:10.1126/science.1253735 · Cited by 426 · see citing works
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Nikolaev, S. I., Rimoldi, D., Iseli, C., Valsesia, A., Robyr, D., Gehrig, C., Harshman, K., Guipponi, M., Bukach, O. V., Zoete, V., et al. (2011) · Nature Genetics · doi:10.1038/ng.1026 · Cited by 410 · see citing works
Krüppel-like factors in cancer
Tétreault, M.-P., Yang, Y., & Katz, J. P. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3582 · Cited by 401 · see citing works
Control of pRB phosphorylation
Mittnacht, S. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80057-9 · Cited by 385 · see citing works
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J. B., Bernards, R., DeCaprio, J. A., & Ewen, M. E. (1997) · Nature · doi:10.1038/386177a0 · Cited by 357 · see citing works
Utikal, J., Maherali, N., Kulalert, W., & Hochedlinger, K. (2009) · Journal of Cell Science · doi:10.1242/jcs.054783 · Cited by 348 · see citing works
Wei, D., Gong, W., Kanai, M., Schlunk, C., Wang, L., Yao, J. C., Wu, T., Huang, S., & Xie, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3619 · Cited by 300 · see citing works
Induction of cyclin D1 overexpression by activated ras.
Filmus, J., Robles, A. I., Shi, W., Wong, M. J. H., Colombo, L. L., & Conti, C. J. (1994) · PubMed · Cited by 295 · see citing works
Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage
Yoon, H. S., Chen, X., & Yang, V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211027200 · Cited by 266 · see citing works
Platz, A., Egyházi, S., Ringborg, U. K., & Hansson, J. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.12.003 · Cited by 261 · see citing works
Katz, J. P., Perreault, N., Goldstein, B. G., Actman, L., McNally, S. R., Silberg, D. G., Furth, E. E., & Kaestner, K. H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.022 · Cited by 246 · see citing works
Deciphering the retinoblastoma protein phosphorylation code
Rubin, S. M. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.10.007 · Cited by 244 · see citing works
A GLI1‐p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B. A., & Altaba, A. R. I. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 233 · see citing works
Self-citationSOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
Santini, R., Pietrobono, S., Pandolfi, S., Montagnani, V., D’Amico, M., Penachioni, J. Y., Vinci, M. C., Borgognoni, L., & Stecca, B. A. (2014) · Oncogene · doi:10.1038/onc.2014.71 · Cited by 200 · see citing works
Self-citationFoster, K. W., Liu, Z., Nail, C. D., Li, X., FitzGerald, T. J., Bailey, S. K., Frost, A. R., Louro, I. D., Townes, T. M., Paterson, A. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208307 · Cited by 196 · see citing works
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4
Kim, M. O., Kim, S.-H., Cho, Y., Nadas, J., Jeong, C., Yao, K., Kim, D. J., Yu, D.-H., Keum, Y.-S., Lee, K.-Y., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2217 · Cited by 179 · see citing works
Role of Krüppel-like factor 4 in normal homeostasis, cancer, and stem cells
Evans, P., & Liu, C.-M. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00439.x · Cited by 165 · see citing works
HEDGEHOG-GLI Signaling Drives Self-Renewal and Tumorigenicity of Human Melanoma-Initiating Cells
Santini, R., Vinci, M. C., Pandolfi, S., Penachioni, J. Y., Montagnani, V., Olivito, B., Gattai, R., Pimpinelli, N., Gerlini, G., Borgognoni, L., et al. (2012) · Stem Cells · doi:10.1002/stem.1160 · Cited by 158 · see citing works
Self-citationWei, D., Wang, L., Yan, Y., Jia, Z., Gagea, M., Li, Z., Zuo, X., Kong, X., Huang, S., & Xie, K. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.005 · Cited by 156 · see citing works
Wei, D., Kanai, M., Jia, Z., Le, X., & Xie, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5953 · Cited by 142 · see citing works
Nandan, M. O., McConnell, B. B., Ghaleb, A. M., Bialkowska, A. B., Sheng, H., Shao, J., Babbin, B. A., Robine, S., & Yang, V. W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.023 · Cited by 136 · see citing works
Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein
Mittnacht, S., Paterson, H., Olson, M. F., & Marshall, C. J. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70094-0 · Cited by 130 · see citing works
E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sitesPreprint
Rabinovich, A., Jin, V. X., Rabinovich, R., Xu, X., & Farnham, P. (2008) · Genome Research · doi:10.1101/gr.080622.108 · Cited by 129 · see citing works
Roles of Kruppel-like factor 4 in normal homeostasis, cancer and stem cells
Paul, P., Evans, Chunming, & Liu (2008) · 生物化学与生物物理学报:英文版 · Cited by 128 · see citing works
Yori, J. L., Seachrist, D. D., Johnson, E., Lozada, K. L., Abdul‐Karim, F. W., Chodosh, L. A., Schiemann, W. P., & Keri, R. A. (2011) · Neoplasia · doi:10.1593/neo.11260 · Cited by 121 · see citing works
Regulation of KLF4 Turnover Reveals an Unexpected Tissue-Specific Role of pVHL in Tumorigenesis
Gamper, A. M., Qiao, X., Kim, J. S., Zhang, L., DeSimone, M. C., Rathmell, W. K., & Wan, Y. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.031 · Cited by 90 · see citing works
Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
Hong, S., Yoon, S., Moelling, C., Arthan, D., & Park, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012591 · Cited by 82 · see citing works
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer
Yu, T., Chen, X., Zhang, W., Liu, J., Avdiushko, R., Napier, D. L., Liu, A., Neltner, J. H., Wang, C., Cohen, D. A., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.85 · Cited by 81 · see citing works
Wei, D., Wang, L., Kanai, M., Jia, Z., Le, X., Li, Q., Wang, H., & Xie, K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.022 · Cited by 78 · see citing works
Delaney, A. M., Printen, J. A., Chen, H., Fauman, E. B., & Dudley, D. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7593-7602.2002 · Cited by 75 · see citing works
KLF4 suppresses transformation of pre-B cells by ABL oncogenes
Kharas, M. G., Yusuf, I., Scarfone, V. M., Yang, V. W., Segre, J. A., Huettner, C. S., & Fruman, D. A. (2006) · Blood · doi:10.1182/blood-2006-03-011106 · Cited by 67 · see citing works
Li, J., Zheng, H., Yu, F., Yu, T., Liu, C., Huang, S., Wang, T. C., & Ai, W. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs143 · Cited by 61 · see citing works
HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation
Huang, Y. H., Chen, J., Lu, C., Han, J., Wang, G., Song, C., Zhu, S., Wang, C., Li, G., Kang, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.433 · Cited by 60 · see citing works
Krüppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts
Elkarim, E. A., Hagos, E. G., Ghaleb, A. M., Yu, B., & Yang, V. W. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-89 · Cited by 59 · see citing works
WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function
Pandolfi, S., Montagnani, V., Penachioni, J. Y., Vinci, M. C., Olivito, B., Borgognoni, L., & Stecca, B. A. (2012) · Oncogene · doi:10.1038/onc.2012.502 · Cited by 49 · see citing works
Self-citationFarrugia, M. K., Sharma, S. B., Lin, C.-C., McLaughlin, S. L., Vanderbilt, D. B., Ammer, A. G., Salkeni, M. A., Stoilov, P., Agazie, Y. M., Creighton, C. J., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.65 · Cited by 48 · see citing works
ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry
Korotayev, K., Chaussepied, M., & Ginsberg, D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.012 · Cited by 47 · see citing works
Li, H., Wang, J., Xiao, W. L., Ding, X., Lang, B., Gan, Y., Guo, X., Guan, W., Wang, Z., Hu, Z., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt189 · Cited by 47 · see citing works
Cercek, A., Wheler, J. J., Murray, P. E., Zhou, S., & Saltz, L. B. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0273-z · Cited by 45 · see citing works
HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth
Pandolfi, S., Montagnani, V., Lapucci, A., & Stecca, B. A. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.56 · Cited by 42 · see citing works
Self-citationZhang, L., Zhang, L., Xia, X., He, S., He, H., & Zhao, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8824 · Cited by 42 · see citing works
Garnovskaya, M. N., Mukhin, Y. V., Vlasova, T. M., Grewal, J. S., Ullian, M. E., Tholanikunnel, B. G., & Raymond, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311622200 · Cited by 40 · see citing works
Driscoll, B., Tang, A., Hu, Y.-H., Yan, C. L., Fu, Y., Luo, Y., Wu, K., Shumin, W., Shi, X.-H., Barsky, L. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9463 · Cited by 39 · see citing works
Muthusamy, V., Premi, S., Soper, C., Platt, J. T., & Bosenberg, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.48 · Cited by 32 · see citing works
Yang, Y., & Katz, J. P. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1156260 · Cited by 28 · see citing works
Camacho‐Vanegas, O., Till, J. E., Miranda‐Lorenzo, I., Ozturk, B., Camacho, S. C., & Martignetti, J. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-220319 · Cited by 21 · see citing works
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function
Pützer, B. M., Steder, M., & Alla, V. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.153 · Cited by 19 · see citing works
Montagnani, V., Benelli, M., Apollo, A., Pescucci, C., Licastro, D., Urso, C., Gerlini, G., Borgognoni, L., Luzzatto, L., & Stecca, B. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8758 · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,920 · see citing works
KLF4 transcription factor in tumorigenesis
He, Z., He, J., & Xie, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01416-y · Cited by 149 · see citing works
Vivas, Y., Falletta, P., Liebing, J., Louphrasitthiphol, P., Feng, Y., Chauhan, J. S., Scott, D. A., Glodde, N., Chocarro‐Calvo, A., Bonham, S., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.014 · Cited by 143 · see citing works
Köhler, C., Nittner, D., Rambow, F., Radaelli, E., Stanchi, F., Vandamme, N., Baggiolini, A., Sommer, L., Berx, G., van den Oord, J. J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.003 · Cited by 126 · see citing works
E2F7−EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
Yang, R., Wang, M., Zhang, G., Bao, Y., Wu, Y., Li, X., Yang, W., & Cui, H. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01032-y · Cited by 116 · see citing works
Pietrobono, S., Anichini, G., Sala, C., Manetti, F., Almada, L. L., Pepe, S., Carr, R. M., Paradise, B. D., Sarkaria, J. N., Davila, J. I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19575-2 · Cited by 90 · see citing works
Self-citationBrown, D. A., Altermatt, M., Dobreva, T., Chen, S., Wang, A. Z., Thomson, M. W., & Gradinaru, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730825 · Cited by 58 · see citing works
The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth
Jia, Y., Ying, X., Zhou, J., Chen, Y., Luo, X., Xie, S., Wang, Q. C., Hu, W., & Wang, L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0580-3 · Cited by 50 · see citing works
Zhang, D., Lin, J., Chao, Y., Zhang, L., Jin, L., Li, N., He, R., Ma, B., Zhao, W., & Han, C. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0842-z · Cited by 47 · see citing works
Chen, Z., Gao, Y., Gao, S., Song, D., & Ye, F. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.87761 · Cited by 46 · see citing works
CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling
Wu, F., & Zhou, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6269-x · Cited by 45 · see citing works
Zhu, Z., Yu, Z., Wang, J., Zhou, L., Zhang, J., Yao, B. W., Dou, J., Qiu, Z., & Huang, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488426 · Cited by 44 · see citing works
Kim, G., Kim, J., Lim, S., Lee, K. Y., Kim, O., & Choi, H. S. (2018) · The FASEB Journal · doi:10.1096/fj.201700645rrrrr · Cited by 44 · see citing works
Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
Ponomarev, A., Gilazieva, Z., Solovyeva, V. V., Allegrucci, C., & Rizvanov, A. A. (2022) · Cancers · doi:10.3390/cancers14040970 · Cited by 44 · see citing works
A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy
Zhou, Z., Feng, Z., Hu, D. G., Yang, P., Gür, M., Bahar, İ., Cristofanilli, M., Gradishar, W. J., Xie, X.-Q., & Wan, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.011 · Cited by 42 · see citing works
Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1227884 · Cited by 41 · see citing works
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Zhang, S., Yang, R., Ouyang, Y., Shen, Y., Hu, L., & Xu, C. S. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0333 · Cited by 41 · see citing works
Ritter, A., Kreis, N., Roth, S., Friemel, A., Jennewein, L., Eichbaum, C., Solbach, C., Louwen, F., & Yuan, J. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1373-z · Cited by 40 · see citing works
miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10
Wu, K., Mu, X., Jiang, J., Tan, M., Wang, R., Zhou, W., Wang, X., He, Y., Li, M., & Liu, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6734 · Cited by 39 · see citing works
Liao, S., Kuo, I., Chen, Y., Liao, P., Liu, Y., Wu, H., Lai, W., & Wang, Y. (2019) · Oncogene · doi:10.1038/s41388-019-0928-x · Cited by 39 · see citing works
Pietrobono, S., Gaudio, E., Gagliardi, S., Zitani, M., Carrassa, L., Migliorini, F., Petricci, E., Manetti, F., Makukhin, N., Bond, A. G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01783-9 · Cited by 39 · see citing works
Self-citationNew insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy
Zeng, L., Zhu, Y., Moreno, C. S., & Wan, Y. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.003 · Cited by 37 · see citing works
Najm, P., Zhao, P., Steklov, M. Y., Sewduth, R. N., Baietti, M. F., Pandolfi, S., Criem, N., Lechat, B., Maia, T. M., Haver, D. V., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3669 · Cited by 37 · see citing works
Liu, J., Cao, F., Li, X., Zhang, L., Li, X., Li, X., Lin, J., & Han, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03707-7 · Cited by 35 · see citing works
Makhmalzadeh, B. S., Molavi, O., Vakili, M. R., Zhang, H., Solimani, A., Abyaneh, H. S., Löebenberg, R., Lai, R. L., & Lavasanifar, A. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps29726 · Cited by 30 · see citing works
EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis
Wang, K., Wang, Y., Wang, Y., Liu, S., Wang, C., Zhang, S., Zhang, T., & Yang, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02256-2 · Cited by 29 · see citing works
Krüppel-like factors in tumors: Key regulators and therapeutic avenues
Zhang, Y., Yao, C., Ju, Z., Jiao, D., Hu, D., Li, Q., Liu, S., Wu, X., & Chen, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1080720 · Cited by 28 · see citing works
Pang, L., Xu, L., Yuan, C., Li, X., Zhang, X., Wang, W., Guo, X., Ouyang, Y., Qiao, L., Wang, Z., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23102 · Cited by 27 · see citing works
Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma
Yoganandarajah, V., Patel, J., van Schaijik, B., Bockett, N., Brasch, H. D., Paterson, E., Sim, D., Davis, P. F., Roth, I. M., Itinteang, T., et al. (2020) · Cells · doi:10.3390/cells9020324 · Cited by 26 · see citing works
Nakajima, W., Miyazaki, K., Asano, Y., Kubota, S., & Tanaka, N. (2021) · Genes · doi:10.3390/genes12040539 · Cited by 25 · see citing works
Ni, Y., Chien, P., Hsieh, H.-C., Shen, H., Lee, H., Chen, S.-M., & Chang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113276 · Cited by 24 · see citing works
Single-cell trajectories of melanoma cell resistance to targeted treatment
Schmidt, M., Mortensen, L. S., Loeffler‐Wirth, H., Kosnopfel, C., Krohn, K., Binder, H., & Kunz, M. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0267 · Cited by 21 · see citing works
Exosome-derived Small RNAs in mouse Sertoli cells inhibit spermatogonial apoptosis
Gao, H., Cao, H., Li, Z., Li, L., Guo, Y., Chen, Y., Peng, G., Zeng, W., Du, J., Dong, W., et al. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.02.011 · Cited by 22 · see citing works
Taqi, M. O., Saeed‐Zidane, M., Gebremedhn, S., Salilew‐Wondim, D., Khadrawy, O., Rings, F., Neuhoff, C., Hoelker, M., Schellander, K., & Tesfaye, D. (2019) · Molecular Reproduction and Development · doi:10.1002/mrd.23272 · Cited by 19 · see citing works
Babaei, K., Khaksar, R., Zeinali, T., Hemmati, H., Bandegi, A., Samidoust, P., Ashoobi, M. T., Hashemian, H., Delpasand, K., Talebinasab, F., et al. (2019) · Biomedicine · doi:10.1051/bmdcn/2019090422 · Cited by 19 · see citing works
Montagnani, V., Maresca, L., Apollo, A., Pepe, S., Carr, R. M., Fernández-Zapico, M. E., & Stecca, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014615 · Cited by 19 · see citing works
Self-citationGCN5 participates in KLF4-VEGFA feedback to promote endometrial angiogenesis
Cao, C., Zhou, Y., Zhang, Y., Ma, Y., Du, S., Fan, L., Niu, R., Zhang, Y., & He, M. (2022) · iScience · doi:10.1016/j.isci.2022.104509 · Cited by 19 · see citing works
Kitazawa, S., Takaoka, Y., Ueda, Y., & Kitazawa, R. (2021) · International Journal of Cancer · doi:10.1002/ijc.33687 · Cited by 18 · see citing works
Wang, C., Okita, Y., Zheng, L., Shinkai, Y., Manevich, L., Chin, J. M., Kimura, T., Suzuki, H., Kumagai, Y., & Kato, M. (2021) · Cancer Science · doi:10.1111/cas.15090 · Cited by 17 · see citing works
Context-dependent functions of KLF4 in cancers: Could alternative splicing isoforms be the key?
Wang, L., Shen, F., Stroehlein, J. R., & Wei, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.005 · Cited by 17 · see citing works
Glioma cell proliferation is inhibited by miR-342-3p, miR-377/E2F1 signaling pathway
Ying, H., & Chi, C. (2019) · Neoplasma · doi:10.4149/neo_2018_180805n574 · Cited by 17 · see citing works
Kyriakou, G., & Melachrinou, M. (2020) · Future Oncology · doi:10.2217/fon-2020-0151 · Cited by 17 · see citing works
A pituitary gene network linking vgll3 to regulators of sexual maturation in male Atlantic salmon
Ahi, E. P., Sinclair‐Waters, M., Donner, I., & Primmer, C. R. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111337 · Cited by 12 · see citing works
Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies
Kilmister, E. J., Hansen, L., Davis, P. F., Hall, S. R. R., & Tan, S. T. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2020.610758 · Cited by 15 · see citing works
Zhang, Z., Wu, Y., Fu, J., Yu, X., Su, Y., Jia, S., Cheng, H., Shen, Y., He, X., Ren, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48173-9 · Cited by 14 · see citing works
Li, X., Jiang, Y., Wang, Y., Li, N., Zhang, S., Lv, K., Jia, R., Wei, T., Li, X., Han, C., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116197 · Cited by 14 · see citing works
Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma
Leick, K. M., Obeid, J. M., Bekiranov, S., & Slingluff, C. L. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1665978 · Cited by 14 · see citing works
Liao, R., Xie, B., Cui, J., Qi, Z., Xue, S., & Wang, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1972194 · Cited by 14 · see citing works
A Combined Antitumor Strategy Mediated by a New Targeted Nanosystem to Hepatocellular Carcinoma
Farinha, D., Migawa, M. T., Sarmento‐Ribeiro, A. B., & Faneca, H. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s302288 · Cited by 14 · see citing works
DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma
Jia, X., Li, L., Wang, F., Xue, Y., Wu, T., Jia, Q., Li, Y., Wu, C., Chen, Y., Wu, J., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00988-5 · Cited by 14 · see citing works
Yu, R., Han, L., Ni, X., Wang, M., Xue, P., Zhang, L., & Yuan, M. (2017) · Tumor Biology · doi:10.1177/1010428317705574 · Cited by 13 · see citing works
KLF4: a multifunctional nexus connecting tumor progression and immune regulation
Ju, Y., Xiao, W., Mathis, B. J., & Shi, Y. Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1514780 · Cited by 13 · see citing works
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
Xu, C., Liang, T. B., Zhang, F., Liu, J., & Fu, Y. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04167-8 · Cited by 13 · see citing works
Lin, X., Song, Q., Kuati, A., Li, Z., Zhou, H., Feng, S., Wang, M., Zhu, S., Cui, G., Wang, J., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70004 · Cited by 12 · see citing works
Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids
Ponomarev, A. S., Gilazieva, Z., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070106 · Cited by 11 · see citing works
Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma
Ingold, N., Seviiri, M., Ong, J., Neale, R. Ε., Pandeya, N., Whiteman, D. C., Olsen, C. M., Martin, N. G., Duffy, D. L., Khosrotehrani, K., et al. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.2601 · Cited by 11 · see citing works
Genomic Landscape of Meningiomas
Wang, J. Z., Nassiri, F., Mawrin, C., & Zadeh, G. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_11 · Cited by 11 · see citing works
Ohya, S., Matsui, M., Kajikuri, J., Endo, K., & Kito, H. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000395 · Cited by 11 · see citing works
Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis
Lee, E., Cheung, J., & Bialkowska, A. B. (2023) · Cancers · doi:10.3390/cancers15092430 · Cited by 11 · see citing works
Sanna, M., Li, X., Visconti, A., Freidin, M. B., Sacco, C., Ribero, S., Hysi, P. G., Bataille, V. A., Han, J., & Falchi, M. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.08.014 · Cited by 12 · see citing works
Embryonic Stem Cell-like Population in Hypertrophic Port-wine Stain
Williams, J. K., Brasch, H. D., Bockett, N. A., Patel, J., Paterson, E., Davis, P. F., & Tan, S. T. (2021) · Journal of Vascular Anomalies · doi:10.1097/jova.0000000000000006 · Cited by 9 · see citing works
Zhang, Z., Chen, H., Liu, L., Zhao, G., He, J., Liu, H., Zhou, C., Liu, X., Sun, X., & Guo, Z. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113596 · Cited by 8 · see citing works
Shi, S., Chen, H., Wang, H., Wan, J., Shi, Y., Li, J., Wang, S., Shi, J., Lv, J., Wu, T., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04160-5 · Cited by 7 · see citing works
Mohan, N., Dashwood, R. H., & Rajendran, P. (2024) · Cancers · doi:10.3390/cancers16061104 · Cited by 7 · see citing works
Li, X., Zhao, Z., Yi, S., Ma, L., Li, M., Liu, M., Zhang, Y., & Liu, G. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1561-0 · Cited by 7 · see citing works
Chang, J., & Xiao, G. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117268 · Cited by 6 · see citing works
CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma
Simbulan-Rosenthal, C. M., Islam, N., Haribabu, Y., Alobaidi, R., Shalamzari, A. F., Graham, G. T., Kuo, L., Sykora, P., & Rosenthal, D. S. (2024) · Cells · doi:10.3390/cells13090777 · Cited by 6 · see citing works
TIPE2 inhibits melanoma progression through MEK/ERK signaling
Gao, X., Li, Y., Wang, C., & Zhao, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-76794-z · Cited by 5 · see citing works
Cai, W., & Chen, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s447934 · Cited by 5 · see citing works
Mandal, J., Jones, T. N., Liberto, J. M., Gaillard, S. L., Wang, T., & Shih, I. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0769 · Cited by 5 · see citing works
Spatiotemporal Labeling of Melanocytes in Mice
Preston, S., Aras, S., & Zaidi, M. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051469 · Cited by 4 · see citing works
Wei, R., Zhang, X., Li, X., Wen, J., Liu, H., Fu, J., Li, L., Zhang, W., Liu, Z., Yang, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01150-z · Cited by 4 · see citing works
Mentucci, F. M., Nuñez, E. A. R., Ercole, A., Silvetti, V., Col, J. D., & Lamberti, M. J. (2024) · Cancers · doi:10.3390/cancers16142568 · Cited by 4 · see citing works
Khan, A. Q., Al-Tamimi, M., Anver, R., Agha, M. V., Anamangadan, G., Raza, S. S., Ahmad, F., Ahmad, A., Alam, M. A., Buddenkotte, J., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167286 · Cited by 3 · see citing works
Özdil, B., Avcı, Ç. B., Calik-Kocaturk, D., Gorgulu, V., Uysal, A., Güler, G., Yavaşoğlu, N. Ü. K., & Aktuğ, H. (2025) · ACS Omega · doi:10.1021/acsomega.5c00799 · Cited by 3 · see citing works
The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity
Sahranavardfard, P., Izadpanah, A., Yasavoli‐Sharahi, H., Firouzi, J., Masoumeh, A., Khosravani, P., Dorraj, M., Keighobadi, F., & Marzieh, E. (2024) · Melanoma Research · doi:10.1097/cmr.0000000000000931 · Cited by 3 · see citing works
Association of Inherited Genetic Variants with Multiple Primary Melanoma
Gibbs, D. C., Small, B. M., Autuori, I., Leong, S. F., Ali, E., Kenney, J., Luo, L., Kanetsky, P. A., BUSAM, K. J., Cust, A. E., et al. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1442 · Cited by 3 · see citing works
The hipotises of the immune system's role in carcinogenesis
Slepov, Y. K., Laushkin, M. A., & Deev, R. V. (2021) · Genes and Cells · doi:10.23868/202104013 · Cited by 3 · see citing works
TMPRSS11B promotes an acidified microenvironment and immune suppression in squamous lung cancer
Sunil, H. S., Clemenceau, J. R. V., Grichuk, A., Barnfather, I., Nakkireddy, S. R., Izzo, L., Feng, Q., Hartnett, W., Evers, B. M., Thomas, L., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00631-1 · Cited by 2 · see citing works
Fan, N., Sun, Y., Yan, L., Chen, W., Wang, Y., Wang, S., & Song, Y. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-01048-y · Cited by 2 · see citing works
Cai, M., Wang, L., Sun, M., Liu, M., & Liu, Y. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70034 · Cited by 1 · see citing works
Cao, C., Li, J., Zhang, Y., Wu, S., Liu, Q., Xi, Y., Chen, C., & He, M. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120658 · Cited by 1 · see citing works
ATAD2 drives melanoma growth and progression and inhibits ferroptosis
Mari, A., Graciano, K., Kumar, R., Giles, E., Ball, P. M., Narayana, R. V. L., & Gupta, R. (2025) · EMBO Reports · doi:10.1038/s44319-025-00660-w · Cited by 1 · see citing works
Wang, L., Jiang, J., Yin, H., Wu, J., Su, X., Meng, L., Wang, L., Bao, J., Li, Q., Wei, Y., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.009 · Cited by 1 · see citing works
Cui, H., Pei, H., Min, F., Wang, Y., Long, Y., Chen, X., Chen, L., Zhou, X., Xing, L., Wen, W., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158737 · Cited by 1 · see citing works
Liu, Y., Chen, P., Chen, G., & Chen, X. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05431-y · Cited by 1 · see citing works
Expression of HOXC10 gene regulates the growth and invasion of prostate cancer cells
Song, H., Ye, X., Liang, T., Yan, D., & Li, Z. (2021) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v16i1.50244 · Cited by 1 · see citing works
Aktuğ, H., Özdil, B., Avci, Ç. B., Calik-Kocaturk, D., Gorgulu, V., Uysal, A., Güler, G., & Yavaşoğlu, N. Ü. K. (2024) · Research Square · doi:10.21203/rs.3.rs-4808028/v1 · Cited by 1 · see citing works
Zhang, L., Li, Z., Wen, X., Nie, W., Wu, R., & Zhang, G. (2017) · Nanoscience and Nanotechnology Letters · doi:10.1166/nnl.2017.2569
Tran, T. M., Philipp, J., Bassi, J. S., Nibber, N., Draper, J. M., Lin, T. L., Palanichamy, J. K., Jaiswal, A. K., Silva, O., Paing, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.20.423624
Diagnosis of melanocytic neoplasms: a literature review
Olisova, O. Y., Pritulo, O. A., & Kirilyuk, T. I. (2020) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv48837
Yu, Y., Tao, M., Xu, L., Cao, L., Le, B., An, N., Dong, J., Xu, Y., Yang, B., Li, W., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0560
Talebinasab, F., Bandegi, A., Naebi, H., Hemmati, H., Samidoust, P., Delshad, M. S. E., Norollahi, S. E., Vahidi, S., Karimian, P., Najafzadeh, A., et al. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101465
Zheng, L., Zheng, X., Ren, X., Hunag, P., Wang, K., Yu, Z., Zeng, M., Liu, T., & Zhou, L. (2021) · Research Square · doi:10.21203/rs.3.rs-927244/v1
Effect of mPFC KLF4 on autism-like behaviors and possible mechanismsPreprint
Ge, T., Zhao, H., Dong, M., Yang, W., Li, B., & Cui, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1728882/v1
Najm, P., Zhao, P., Steklov, M. Y., Sewduth, R. N., Baietti, M. F., Pandolfi, S., Criem, N., Lechat, B., Maia, T. M., Haver, D. V., et al. (2023) · doi:10.1158/0008-5472.c.6513261.v1
Molecular mechanisms of tumor cell stemness modulation during formation of spheroids: a review
Ponomarev, A. S., Gilazieva, Z., Solovyova, V. V., & Rizvanov, A. A. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523070102
Sunil, H. S., Clemenceau, J. R. V., Barnfather, I., Nakkireddy, S. R., Grichuk, A., Izzo, L., Evers, B. M., Thomas, L. B., Subramaniyan, I., Li, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646727
Xu, C., Liang, T., Zhang, F., Liu, J., & Fu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14570602
- Authors
- Riverso, M., Montagnani, V, & Stecca, B.
- Affiliations
- Tumour Institute of Tuscany (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Stecca, B
- ORCID
- Stecca, B
- Venue
- Oncogene
- Published
- 2017-01-09
- Volume
- 36
- Issue
- 23
- Pages
- 3322-3333
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC5474568
- OpenAlex
- W2567939958
- Cited by
- 115
- References
- 61
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 23 · 2023: 13 · 2022: 8 · 2021: 25 · 2020: 9 · 2019: 11 · 2018: 9 · 2017: 3
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Oncogene (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Istituto Toscano Tumori
- Università degli Studi di Firenze
- Associazione Italiana per la Ricerca sul Cancro (IG-14184)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- KLF4, melanoma, RAS/MAPK pathway, MAPK signaling, E2F1, ERK1/2, transcriptional regulation, cell proliferation, apoptosis, xenograft tumor growth, therapeutic target
- MeSH terms
- Kruppel-Like Factor 4, Animals, Female, Humans, Melanoma, Mice, Nude, Skin Neoplasms, Tumor Cells, Cultured, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Apoptosis, ras Proteins, Xenograft Model Antitumor Assays, Extracellular Signal-Regulated MAP Kinases, MAP Kinase Kinase 1, raf Kinases, Cell Proliferation, E2F1 Transcription Factor, Mice, Kruppel-Like Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review